Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorGangnam Severance Hospital

About this trial

This study aims to assess whether transmusculr quadratus lomborum block (QL block) can reduce postoperative pain after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (CRS and HIPEC). Patients will be randomly assigned to either QL block group or control group. Ultrasound-guided bilateral transmuscular quadratus lomborum block will be performed in QL block group using 0.375% ropivacaine. Multimodal analgesic regimen including acetaminophen, nonsteroidal antiinflammatory drugs (NSAIDs), and rescue opioids will be used in every patient. Primary outcome is opioid consumption for 24 hours after surgery. Secondary outcomes included pain scores, time to first rescue analgesics, quality of recovery score, length of hospital stay.

Eligibility criteria

Qualifiers

None

Disqualifiers

Allergy to local anesthetics or fentanyl

Chronic pain

Drug abuse

Patients who are unable to use patient-controlled analgesia

Trial design

Treatments tested in this trial

  • Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators